Nisa Investment Advisors LLC Has 26.67 Million Stake in Zoetis Inc.
| PHPSX Fund | USD 22.67 0.07 0.31% |
Slightly above 53% of Pharmaceuticals Ultrasector's investor base is interested to short. The analysis of overall sentiment of trading Pharmaceuticals Ultrasector Profund mutual fund suggests that many investors are impartial at this time. Pharmaceuticals Ultrasector's investing sentiment can be driven by a variety of factors including economic data, Pharmaceuticals Ultrasector's earnings reports, geopolitical events, and overall market trends.
Pharmaceuticals |
Nisa Investment Advisors LLC trimmed its position in shares of Zoetis Inc. by 2.2 percent during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 161,999 shares of the companys stock after selling 3,691 shares during the period. Nisa Investment
Read at thelincolnianonline.com
 |
Pharmaceuticals Ultrasector Fundamental Analysis
We analyze Pharmaceuticals Ultrasector's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmaceuticals Ultrasector using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmaceuticals Ultrasector based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Pharmaceuticals Ultrasector is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Pharmaceuticals Ultrasector Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmaceuticals Ultrasector mutual fund to make a market-neutral strategy. Peer analysis of Pharmaceuticals Ultrasector could also be used in its relative valuation, which is a method of valuing Pharmaceuticals Ultrasector by comparing valuation metrics with similar companies.
Peers
Pharmaceuticals Ultrasector Related Equities
| UIPIX | Ultrashort Mid-cap | 1.09 | ||||
| BRPSX | Bear Profund | 0.68 | ||||
| LGPSX | Profunds Large | 0.53 | ||||
| LGPIX | Large Cap | 0.53 | ||||
| BRPIX | Bear Profund | 0.20 | ||||
| UIPSX | Ultrashort Mid-cap | 0.36 | ||||
| SRPSX | Short Real | 0.45 | ||||
| SRPIX | Short Real | 0.51 | ||||
| TEPIX | Technology Ultrasector | 2.33 | ||||
| TEPSX | Technology Ultrasector | 2.33 |
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |